Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Implanon NXT in Young Female Soccer Players
NCT06775626Phase 1Suspended
- Start
- Apr 2025
- Primary completion
- Apr 2025
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Phase 1, open-label trial of etonogestrel implant in menstrual disorders (2 arms). Primary endpoints: Anthropometric Measurements at 12 months and Body Composition at 12 months. Started Apr 2025; status: suspended.
02
Drugs
etonogestrel implant
03
Conditions
menstrual disorders
Beyond the preview
Go deeper on NCT06775626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06775626.